Ubiquitous transgenic expression of the IL-23 subunit p19 induces multiorgan inflammation, runting, infertility, and premature death

被引:229
作者
Wiekowski, MT
Leach, MW
Evans, EW
Sullivan, L
Chen, SC
Vassileva, G
Bazan, JF
Gorman, DM
Kastelein, RA
Narula, S
Lira, SA
机构
[1] Schering Plough Corp, Res Inst, Dept Immunol, Kenilworth, NJ 07033 USA
[2] Schering Plough Corp, Res Inst, Dept Drug Safety & Metab, Lafayette, NJ 07848 USA
[3] DNAX Res Inst Mol & Cellular Biol Inc, Palo Alto, CA 94304 USA
关键词
D O I
10.4049/jimmunol.166.12.7563
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
p19, a molecule structurally related to IL-6, G-CSF, and the p35 subunit of IL-12, is a subunit of the recently discovered cytokine IL-23. Here we show that expression of p19 in multiple tissues of transgenic mice induced a striking phenotype characterized by runting, systemic inflammation, infertility, and death before 3 mo of age. Founder animals had infiltrates of lymphocytes and macrophages in skin, lung, liver, pancreas, and the digestive tract and were anemic. The serum concentrations of the proinflammatory cytokines TNF-alpha and IL-1 were elevated, and the number of circulating neutrophils was increased. In addition, ubiquitous expression of p19 resulted in constitutive expression of acute phase proteins in the liver. Surprisingly, liver-specific expression of p19 failed to reproduce any of these abnormalities, suggesting specific requirements for production of biologically active p19. Bone marrow transfer experiments showed that expression of p19 by hemopoietic cells alone recapitulated the phenotype induced by its widespread expression, pointing to hemopoietic cells as the source of biologically active p19. These findings indicate that p19 shares biological properties with IL-6, IL-12, and G-CSF and that cell-specific expression is required for its biological activity.
引用
收藏
页码:7563 / 7570
页数:8
相关论文
共 40 条
  • [1] AN E, 1994, EXP HEMATOL, V22, P149
  • [2] BAKER J, 1993, CELL, V75, P73, DOI 10.1016/0092-8674(93)90680-O
  • [3] BRANDT SJ, 1990, CURR TOP MICROBIOL, V166, P37
  • [4] NEW THREATS AND OPPORTUNITIES EMERGE IN UK POLICY CHANGES
    CAMPBELL, P
    [J]. PHYSICS WORLD, 1993, 6 (07) : 4 - 5
  • [5] STIMULATORY AND INHIBITORY EFFECTS OF INTERLEUKIN (IL)-4 AND IL-13 ON THE PRODUCTION OF CYTOKINES BY HUMAN PERIPHERAL-BLOOD MONONUCLEAR-CELLS - PRIMING FOR IL-12 AND TUMOR-NECROSIS-FACTOR-ALPHA PRODUCTION
    DANDREA, A
    MA, XJ
    ASTEAMEZAGA, M
    PAGANIN, C
    TRINCHIERI, G
    [J]. JOURNAL OF EXPERIMENTAL MEDICINE, 1995, 181 (02) : 537 - 546
  • [6] Interleukin 6 causes growth impairment in transgenic mice through a decrease in insulin-like growth factor-I - A model for stunted growth in children with chronic inflammation
    DeBenedetti, F
    Alonzi, T
    Moretta, A
    Lazzaro, D
    Costa, P
    Poli, V
    Martini, A
    Ciliberto, G
    Fattori, E
    [J]. JOURNAL OF CLINICAL INVESTIGATION, 1997, 99 (04) : 643 - 650
  • [7] SERUM-SOLUBLE INTERLEUKIN-6 (IL-6) RECEPTOR AND IL-6 SOLUBLE IL-6 RECEPTOR COMPLEX IN SYSTEMIC JUVENILE RHEUMATOID-ARTHRITIS
    DEBENEDETTI, F
    MASSA, M
    PIGNATTI, P
    ALBANI, S
    NOVICK, D
    MARTINI, A
    [J]. JOURNAL OF CLINICAL INVESTIGATION, 1994, 93 (05) : 2114 - 2119
  • [8] AIRWAY EPITHELIAL-CELL EXPRESSION OF INTERLEUKIN-6 IN TRANSGENIC MICE - UNCOUPLING OF AIRWAY INFLAMMATION AND BRONCHIAL HYPERREACTIVITY
    DICOSMO, BF
    GEBA, GP
    PICARELLA, D
    ELIAS, JA
    RANKIN, JA
    STRIPP, BR
    WHITSETT, JA
    FLAVELL, RA
    [J]. JOURNAL OF CLINICAL INVESTIGATION, 1994, 94 (05) : 2028 - 2035
  • [9] DUHRSEN U, 1988, BLOOD, V72, P2074
  • [10] FATTORI E, 1994, BLOOD, V83, P2570